Quebec Network Réseau Québécoise de l’Amyotrophie Spinale Joins NMD4C as Community of Practice Sub-Group
We are thrilled to announce that the Réseau Québécoise de l’Amyotrophie Spinale (RQAS), a network uniting rehabilitation clinicians across Quebec to advance the care of people with Spinal Muscular Atrophy (SMA) since 2022, has officially become a sub-group Community of Practice of the Neuromuscular Disease Network of Canada (NMD4C).
This marks an exciting milestone for both the NMD4C and RQAS members, offering significant new opportunities and resources.
By welcoming the RQAS, the NMD4C gains:
- A well-established community of practice of 136+ members, including clinicians, researchers, and patient partners.
- Stronger French-Canadian representation, ensuring diverse perspectives in care, research, and policy.
- A proven model for clinician-driven collaboration, expanding best practices across neuromuscular diseases.
As a sub-group of the NMD4C, the RQAS will benefit from:
- Greater access to support for research, training, and initiatives to improve neuromuscular care.
- Enhanced organizational support, streamlining activities for greater efficiency.
- A broader national network, fostering collaboration, knowledge-sharing, and innovation.
Through incorporating RQAS into NMD4C, we will continue our efforts to unify, support, and advance neuromuscular care and research across Canada. We look forward to working together to drive innovation and improve outcomes for individuals with neuromuscular diseases. If you have any questions, contact our Community of Practice Manager.
Read next...
Save the Date: 2027 Neuromuscular Postdoctoral Fellowship Funding Competition
The 2027 NMD4C/MDC Neuromuscular Postdoc Fellowship Funding Competition will open for applications on September 2, 2026. Our annual funding competition awards salary support for early-career scientists pursuing postdoctoral studies in neuromuscular disease research.
Spinal Muscular Atrophy (SMA) Awareness Month – Research Spotlight
August is Spinal Muscular Atrophy (SMA) Awareness Month, and we are thrilled to feature high-impact research led by members of the NMD4C community!
Published recently in Annals of Neurology, a study titled “Maternal-Fetal Administration of Risdiplam Partially Rescues the SMNΔ7 Mouse Model of Spinal Muscular Atrophy” explores the potential of early prenatal therapeutic interventions for SMA.
